Cardinal Health Tops Fiscal Q4 Street Marks On EPS and Revenues

Cardinal Health Tops Fiscal Q4 Street Marks On EPS and Revenues

Cardinal Health, distributor of healthcare products to hospitals, clinics and others, Wednesday reported fiscal Q4 results ended June 30 which beat expectations and issued downside EPS guidance for FY18. The company posted fiscal Q4 adjusted EPS of $1.31, seven cents above the Street view as compiled by Capital IQ, and also above the $1.14 reported a year earlier. Cardinal Health reported fiscal Q4 revenue of $32.97 billion, a little above […]

Read More ˃
Cogentix Acquires Genesis Medical

Cogentix Acquires Genesis Medical

Cogentix Medical, a medical device maker in the urology and gynecology markets, said Wednesday it has acquired the privately held, UK-based Genesis Medical. The company said it purchased the tangible assets of Genesis Medical and said it will pay up to GBP515,000 ($672,000) for the ongoing business, dependent on Genesis achieving certain revenue milestones through March 2019. Cogentix said the transaction is expected to generate incremental revenue in H2 of […]

Read More ˃
Diebold Nixdorf Posts Q2 Beat

Diebold Nixdorf Posts Q2 Beat

Diebold Nixdorf shares were higher 5.4% in pre-market trade after the company reported financial results for Q2, with earnings and revenue that topped analysts’ expectations; it also provided guidance for fiscal 2017 in line with Street estimates. The provider of connected commerce services, software and technology posted non-GAAP earnings of $0.08 per share, compared with the prior-year period’s $0.43 per share. Analysts polled by Capital IQ were expecting EPS of […]

Read More ˃
Radius Health Strikes License Deal

Radius Health Strikes License Deal

Radius Health, a biopharmaceutical company, said Thursday it has entered into a license and development agreement with Teijin Limited for the commercialization in Japan of its abaloparatide injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Teijin is developing the drug in Japan under an agreement with Ipsen Pharma and has launched a phase 3 trial. The collaboration agreement provides Teijin with the right to […]

Read More ˃
Blackstone Enters Deal to Acquire International Market Centers

Blackstone Enters Deal to Acquire International Market Centers

The Blackstone Group L.P said Thursday that funds managed by Blackstone Real Estate Partners and Blackstone Tactical Opportunities have entered into a definitive agreement to acquire International Market Centers, Inc. from Bain Capital Private Equity and funds managed by Oaktree Capital Management (OAK). Financial terms weren’t disclosed. International Market Centers is an owner and operator of premier showroom space for the furnishings, home decor and gift industries. The transaction is […]

Read More ˃